[Federal Register Volume 86, Number 246 (Tuesday, December 28, 2021)]
[Notices]
[Pages 73794-73795]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-28087]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Sickle Cell Disease
Advisory Committee.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Sickle Cell Disease Advisory Committee.
Date: January 25, 2022.
Time: 10:00 a.m. to 1:30 p.m.
Agenda: Presentations and discussion of programs.
Place: National Institutes of Health, Rockledge II, 6705
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Telephone Access: 1-646-828-7666 (Meeting ID: 160 241 4559)
Passcode: 076579.
Virtual Access: https://nih.zoomgov.com (Meeting ID: 160 241
4559) Passcode: 076579.
Contact Person: W. Keith Hoots, MD., Director, Division of Blood
Diseases and Resources, National Heart, Lung, and Blood Institute,
6705 Rockledge Drive, Bethesda, MD 20892, 301-435-0080,
[email protected].
Any member of the public interested in presenting oral comments
to the committee may notify the Contact Person listed on this notice
at least 10 days in advance of the meeting. Interested individuals
and representatives of organizations may submit a letter of intent,
a brief description of the organization represented, and a short
description of the oral presentation. Only one representative of an
organization may be allowed to present oral comments and if accepted
by the committee, presentations may be limited to five minutes. Both
printed and electronic copies are requested for the record. In
addition, any interested person may file written comments with the
committee by forwarding their statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: www.nhlbi.nih.gov/meetings/index.htm, where an agenda and any
additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases
[[Page 73795]]
and Resources Research, National Institutes of Health, HHS)
Dated: December 21, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-28087 Filed 12-27-21; 8:45 am]
BILLING CODE 4140-01-P